Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study

por Florian, Hana, Wang, Deli, Arnold, Steven E, Boada, Mercè, Guo, Qi, Jin, Ziyi, Zheng, Hui, Fisseha, Nahome, Kalluri, Hari Varun, Rendenbach-Mueller, Beatrice, Budur, Kumar, Gold, Michael
Publicado 2023